Press "esc" to clear
Go to Advanced Search
Showing results 2130 of 204990
Embargo will expire:
22-Oct-2018 12:00 PM EDT
Released to reporters:
21-Oct-2018 11:05 PM EDT

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 22-Oct-2018 12:00 PM EDT

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Embargo will expire:
22-Oct-2018 12:00 PM EDT
Released to reporters:
21-Oct-2018 11:05 PM EDT

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 22-Oct-2018 12:00 PM EDT

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Embargo will expire:
22-Oct-2018 12:00 PM EDT
Released to reporters:
21-Oct-2018 11:05 PM EDT

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 22-Oct-2018 12:00 PM EDT

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

  • Embargo expired:
    21-Oct-2018 2:10 PM EDT

Article ID: 702529

Study shows surgery, radiation extend survival of patients with limited metastatic lung cancer

University of Texas M. D. Anderson Cancer Center

Radiation or surgical removal of metastatic tumors provides a major survival advantage for lung cancer patients with minimal stage 4 disease who have not progressed after frontline chemotherapy, a study led by researchers from The University of Texas MD Anderson Cancer Center shows.

Released:
20-Oct-2018 2:05 PM EDT
Open in New Tab
Comment
Embargo will expire:
22-Oct-2018 11:00 AM EDT
Released to reporters:
21-Oct-2018 11:00 AM EDT

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 22-Oct-2018 11:00 AM EDT

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

  • Embargo expired:
    21-Oct-2018 6:00 AM EDT

Article ID: 700835

NOW AVAILABLE: Abstracts to be presented at the American Neurological Association’s 143rd Annual Meeting October 21-23, 2018

American Neurological Association (ANA)

Embargoed abstracts to be presented at the American Neurological Association’s 143rd Annual Meeting October 21-23, 2018 at the Hyatt Regency Atlanta are now available to journalists upon request.

Released:
21-Sep-2018 9:00 AM EDT
Open in New Tab
Comment
  • Embargo expired:
    21-Oct-2018 12:00 AM EDT

Article ID: 700198

American Neurological Association highlights abstracts to be presented at the 143rd Annual Meeting October 21-23, 2018 in Atlanta

American Neurological Association (ANA)

Methods to more precisely inject stem cells into the spinal cord; an enzyme that enhances the synthesis of dopamine in people with Parkinson’s disease; a drug that protects against chemotherapy-induced neuropathy – these are just a few of the exciting research findings that will be presented at the American Neurological Association’s 143rd Annual Meeting October 21-23, 2018 at the Hyatt Regency Atlanta.

Released:
12-Sep-2018 9:00 AM EDT
Open in New Tab
Comment
10-19-2018VanessaMTipSheet.jpg
  • Embargo expired:
    20-Oct-2018 5:30 PM EDT

Article ID: 702486

Johns Hopkins Researchers Present at Rheumatology Annual Meeting

Johns Hopkins Medicine

The 2018 American College of Rheumatology/American Rheumatology Health Professionals Annual Meeting.

Released:
19-Oct-2018 11:00 AM EDT
Open in New Tab
Comment
  • Embargo expired:
    20-Oct-2018 5:30 PM EDT

Article ID: 702314

American College of Rheumatology Announces 2018 Award Recipients

American College of Rheumatology (ACR)

The American College of Rheumatology (ACR) announced the 2018 recipients of its Master of the ACR designation, Awards of Distinction, and Distinguished Fellow Award honors during the opening lecture of the 2018 ACR/ARHP Annual Meeting in Chicago. These recognitions are given annually to members who exhibit outstanding contributions to the ACR and the field of rheumatology.

Released:
16-Oct-2018 3:45 PM EDT
Open in New Tab
Comment
  • Embargo expired:
    20-Oct-2018 5:30 PM EDT

Article ID: 702267

ACR AND EULAR Present Draft of the First Classification Criteria for IgG4-Related Disease

American College of Rheumatology (ACR)

The American College of Rheumatology (ACR) and the European League Against Rheumatism (EULAR) will present a draft of the Classification Criteria for IgG4-Related Disease, the first classification criteria developed for this recently recognized disease, during a session at the 2018 ACR/ARHP Annual Meeting this week at McCormick Place in Chicago. The classification criteria are currently under review by the ACR and EULAR for endorsement.

Released:
16-Oct-2018 2:30 PM EDT
Open in New Tab
Comment

Showing results 2130 of 204990

Chat now!